Curve Therapeutics

About Curve Therapeutics

Curve Therapeutics is focused on transforming the lives of patients by developing innovative cyclic peptide and small molecule drugs using their proprietary Microcycle® discovery platform, targeting challenging diseases with a focus on cancer, immunology, and inflammation.

Products & Services

Microcycle® Discovery Platform:A mammalian cell-based platform for discovering biologically active cyclic peptides and small molecules through functional screening in live cells, targeting intracellular disease targets.

Pipeline Drugs:Innovative cyclic peptide and small molecule drugs addressing high-priority intracellular targets in cancer, immunology, and inflammation.

Specialties

Cyclic Peptide Drug Discovery Small Molecule Drug Development Intracellular Target Therapeutics Cancer Treatment Immunology Inflammation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 51435000 MR: - FA: £40.5 million FAN: 51435000	D: 2024-02-27 FD: 2024-02-27	5 investors

Series A Latest

2024-02-27

$51.4M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Simon Kerry

Chief Executive Officer

A

Ali Tavassoli

Professor of Chemical Biology

R

Rab Prinjha

Chief R&D Officer

S

Simon Jones

Chief Financial Officer and Chief Operating Officer

S

Sally Price

Vice President of Biology

R

Richard Rathmell

Vice President of Chemistry

View 18 more team members with Pro

Unlock Full Team Directory

Recent News